Results 131 to 140 of about 39,535 (286)

The FDA Has Ended Required Blood Monitoring for Clozapine Use—Will This Impact the Management of Parkinson's Disease Psychosis?

Movement Disorders, EarlyView.
Daniel Weintraub, Izabelle Schoen
wiley   +1 more source

Impact of Frailty in Patients With Continuous‐Flow Left Ventricular Assist Device Therapy in End‐Stage Heart Failure: A Systematic Review and Meta‐Analysis

Artificial Organs, EarlyView.
Frailty significantly impacts clinical outcomes in LVAD recipients. This systematic review and meta‐analysis reveal that frail patients experience higher long‐term mortality but comparable short‐term mortality, hospital stay, and complication rates to non‐frail patients.
Christos Costa, Arian Arjomandi Rad, Yi Ting Yu, Nithiananthan Mayooran, Andrew Xanthopoulos, Marinos Koulouroudias, Robert Vardanyan, Gustavo Antonio Guida, Lydia Wilkinson, Jan Schmitto, Arjang Ruhparwar, Alina Zubarevich, Alexander Weymann, Peyman Sardari Nia, Antonios Kourliouros, Thanos Athanasiou   +15 more
wiley   +1 more source

Environmental racism and air pollution: Pre and post the COVID‐19 economic shutdown

Review of Policy Research, EarlyView., 2023
Abstract Decades of research demonstrates that minoritized groups are disproportionately affected by swathes of harmful pollutants, including air pollution, even controlling for low income. Would significantly reducing individual car traffic help reduce the EJ gap?
Heather E. Campbell, Sekwen Kim, Shawnika Johnson, Claudia Cáceres   +3 more
wiley   +1 more source

Early defibrillation through first responders doubles sudden cardiac arrest survival in an Italian community Alessandro Capucci, Daniela Aschieri, Massimo F. Piepoli, Efi Iconomu, Maurizio Arvedi. cardiology department, Piacenza, Italy

, 2001

openalex   +1 more source

Physiological Control of Realheart Total Artificial Heart

Artificial Organs, EarlyView.
This study evaluates the Realheart Total Artificial Heart's preload‐based physiological controller, which dynamically adjusts heart rate and stroke volume to mimic the heart's natural responses during sleep, rest, and exercise using a hybrid mock circulation loop of the cardiovascular system.
Emanuele Perra, Daniel Jonasson, Shaikh Faisal Zaman, Nils Brynedal Ignell, Michael Broomé, Thomas Finocchiaro, Ina Laura Perkins, Seraina Anne Dual   +7 more
wiley   +1 more source

A young mountaineer surviving sudden cardiac arrest at high altitude [PDF]

, 2010
Andreas Indermuehle, S Cook, H Marty
openalex   +1 more source

Children and Young Adults Who Used Medication for Attention Deficit Hyperactivity Disorder Faced Increased Cardiac Risks

Acta Paediatrica, EarlyView.
ABSTRACT Aim There have been concerns about links between medication for attention deficit hyperactivity disorder (ADHD) and cardiac events in children and young people. Our aim was to identify any associations. Method This Swedish case–control study used national register data to identify individuals aged 5–30 years who received their first diagnosis ...
Howaida Elmowafi, Jenny M. Kindblom, Linda Halldner, David Gyllenberg, Estelle Naumburg   +4 more
wiley   +1 more source

Socioeconomic status and incidence of sudden cardiac arrest [PDF]

, 2011
Kyndaron Reinier, E. Thomas, Douglas Andrusiek, Tom P. Aufderheide, Steven C. Brooks, Clifton W. Callaway, Paul E. Pepe, Thomas D. Rea, Robert H. Schmicker, Christian Vaillancourt, Sumeet S. Chugh   +10 more
openalex   +1 more source

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

British Journal of Pharmacology, EarlyView.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen, Tamás Kovács, Péter Ferdinandy, Zoltán V. Varga   +3 more
wiley   +1 more source

Matrix metalloproteinase inhibition protects against junctophilin‐2 proteolysis during doxorubicin‐induced cardiotoxicity

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Treatment of cancer patients with anthracyclines is known to cause dose‐dependent cardiotoxicity through several mechanisms including enhanced oxidative stress, ultimately resulting in defective excitation–contraction coupling.
Wesam Bassiouni, Brandon Y. H. Chan, Andrej Roczkowsky, Joshua W. Kranrod, Zabed Mahmud, Joseph O. Primeau, Woo Jung Cho, Howard S. Young, John M. Seubert, Richard Schulz   +9 more
wiley   +1 more source